Inside Innovation

Ora Biomedical is planting roots in the Puget Sound region with plans to open a drug-discovery laboratory. The company recently announced a $500,000 pre-seed round

Seattle-based mental health startup Alongside has received $5.5 million in seed funding, with plans to partner with schools to support adolescent mental health and continue

Preclinical biotech company Sonoma Biotherapeutics has announced plans to build an 83,000-square-foot manufacturing and research center on Seattle’s waterfront. The new facility will be used

Pattern Computer, a Seattle-based startup, is developing a rapid COVID-19 test based on patterns in light from spit. In its seven years as a company,

Monod Bio, a spinout company from the University of Washington’s Institute for Protein Design, has raised $25 million to develop molecular biosensors designed to detect

Violett, a Seattle-based startup specializing in ultraviolet light air purification technology, has raised $2.3 million in a seed funding round led by Tacoma Venture Fund.

Woodinville-based biotech Nortis has raised $6 million in equity funding and is seeking to raise an additional $3.5 million. Nortis focuses on “organ-on-chip” technology and

Seattle-based startup HDT Bio received nearly $1.8 million from the U.S. Army to develop a nasal spray designed to treat a variety of respiratory diseases.

Seattle’s SEngine Precision Medicine has raised $10 million in a new funding round led by The Washington Research Foundation. The new capital will be used

Dr. Anthony Fauci, President Biden’s chief medical advisor, stopped in Seattle to speak with Fred Hutchinson Cancer Center and throw the first pitch at the

Three Seattle-area biotech startups are on the rise, according to venture capital firms placing their bets on who will be taking off over the next

Seattle-based biotech company Seagen recently released early findings from a trial of its drug Padcev in combination with Merck‘s Keytruda to treat patients with specific